IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
14 hedge funds and large institutions have $984K invested in Interpace Biosciences, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$184K | |
| 2 | +$46.2K | |
| 3 | +$39.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.39K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$510 |
Top Sellers
| 1 | -$478K | |
| 2 | -$91K | |
| 3 | -$38.2K | |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$35.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$17K |